[A case report of an advanced esophageal carcinoma (stage II) without signs of recurrence in 5 years after chemoradiotherapy. With reference to p53 immunohistochemistry as an indicator for prognostic evaluation of chemoradiotherapy].
Isogai
Keiki
K
Department of Internal Medicine, Social Welfare Corporation, Hokkaido Social Work Association, Otaru Hospital.
Moriuchi
Reine
R
Tarasawa
Isao
I
Yabana
Takashi
T
Kato
Tomohiro
T
Nakahara
Seiya
S
Murakami
Rieko
R
Senota
Akinori
A
Ban
Toshihiro
T
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
D016159:Tumor Suppressor Protein p53; D002945:Cisplatin; D005472:Fluorouracil